| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/04/2008 | US20080213227 Using animal progenitor cell culture to propagate organ tissues; tissue engineering; tissue repair; regenerative medicine; treating cell proliferative, arthritic, autoimmune, skin and inflammatory disorders |
| 09/04/2008 | US20080213223 Using virus-ligand complex to specifically bind and target cancer cells for destruction; gene therapy |
| 09/04/2008 | US20080213220 Adenovirus vector comprising progression elevated gene-3 (PEG-3) regulatory sequences and E1A tumor suppressor gene for use in targeted destruction of cancer cells; antiproliferative agents |
| 09/04/2008 | US20080213189 Multifunctional metal-graphite nanocrystals |
| 09/04/2008 | US20080213185 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| 09/04/2008 | US20080213171 Cancerous disease modifying antibodies |
| 09/04/2008 | US20080213169 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 09/04/2008 | US20080213168 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 09/04/2008 | US20080213167 administering an anti-CD23 antibody and chlorambucil; B cell chronic lymphocytic leukemia |
| 09/04/2008 | US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas |
| 09/04/2008 | CA2679659A1 Pim kinase inhibitors and methods of their use |
| 09/04/2008 | CA2679629A1 Use of histone deacetylase inhibitors for the treatment of central nervous system metastases |
| 09/04/2008 | CA2679489A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors |
| 09/04/2008 | CA2679435A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases |
| 09/04/2008 | CA2679400A1 Combination therapy for treatment of immune disorders |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2679224A1 Novel compounds |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 09/04/2008 | CA2678043A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 09/04/2008 | CA2678032A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | CA2677075A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | CA2673607A1 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964839A2 Quinazoline derivatives as kinase inhibitors |
| 09/03/2008 | EP1964837A1 Anti-tumor agent for multiple myeloma |
| 09/03/2008 | EP1964835A1 Derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1964569A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections |
| 09/03/2008 | EP1964565A1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1964560A1 Use of inhibitors of the degradation of p27 for the treatment of cancer |
| 09/03/2008 | EP1964557A1 Process for producing arsenic trioxide formulations and methods for treating acute myelogenous leukemia using arsenic trioxide |
| 09/03/2008 | EP1963532A2 Dna methylation as a target for diagnosis and treatment of chronic lymphocytic leukemia (cll) |
| 09/03/2008 | EP1963371A2 Human monoclonal antibodies to o8e |
| 09/03/2008 | EP1963349A1 Novel loganin analogues and a process for the preparation thereof |
| 09/03/2008 | EP1963330A1 Dimers and adducts of 6-[substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 09/03/2008 | EP1963329A2 Inhibitors of c-met and uses thereof |
| 09/03/2008 | EP1963327A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS |
| 09/03/2008 | EP1963326A1 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| 09/03/2008 | EP1963321A2 Dibenzonaphthyridine derivatives and methods of use thereof |
| 09/03/2008 | EP1963320A1 Pyrrolopyridine kinase inhibiting compounds |
| 09/03/2008 | EP1963319A1 Heteroarylpyrrolopyridinones active as kinase inhibitors |
| 09/03/2008 | EP1963316A2 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors |
| 09/03/2008 | EP1963313A2 Inhibitors of diacylglycerol acyltransferase (dgat) |
| 09/03/2008 | EP1963310A2 Methods of preparing a vegf-r inhibitor |
| 09/03/2008 | EP1963302A2 Polymorphs of a c-met/hgfr inhibitor |
| 09/03/2008 | EP1963295A1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives |
| 09/03/2008 | EP1963282A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 09/03/2008 | EP1963272A1 Hydroxyquinoline derivatives |
| 09/03/2008 | EP1963264A2 New 3 -, 7-substituted indirubins and their applications |
| 09/03/2008 | EP1962961A1 Demibodies: dimerisation-activated therapeutic agents |
| 09/03/2008 | EP1962913A2 Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma |
| 09/03/2008 | EP1962904A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 09/03/2008 | EP1962891A1 Dna vaccine for cancer therapy |
| 09/03/2008 | EP1962854A2 Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths |
| 09/03/2008 | EP1962850A1 Treatment of drug-resistant tumors |
| 09/03/2008 | EP1962839A2 Administration of mntor inhibitor to treat patients with cancer |
| 09/03/2008 | EP1962822A1 Therapy of malignant neoplasias |
| 09/03/2008 | EP1919863A4 Process for the production of bicalutamide |
| 09/03/2008 | EP1689404B1 Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer |
| 09/03/2008 | EP1641774B1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators |
| 09/03/2008 | EP1587532B1 Survivin-derived peptides and use thereof |
| 09/03/2008 | EP1545500A4 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 09/03/2008 | EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 09/03/2008 | EP1426443B1 Human bmcc1 gene |
| 09/03/2008 | EP1411118B1 Cell proliferation inhibitors containing anti-glypican-3 antibody |
| 09/03/2008 | EP1385551B1 Antineoplastic combinations comprising cci-779 (rapamycin derivative) together with gemcitabine or fluorouracil |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1137769B1 Methods for the generation of dna libraries |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | EP1112371B1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 09/03/2008 | EP1042293B9 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 09/03/2008 | EP0781331B1 Improvements in or relating to binding proteins for recognition of dna |
| 09/03/2008 | EP0758252B1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
| 09/03/2008 | CN101258238A Method for activation treatment of antigen-presenting cell |
| 09/03/2008 | CN101258162A Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 |
| 09/03/2008 | CN101258130A Isoquinolines as igf-1r inhibitors |
| 09/03/2008 | CN101258129A Quinoline derivatives and use as antitumor agents |
| 09/03/2008 | CN101257948A Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 09/03/2008 | CN101257923A Anti-ccr7 receptor antibodies for the treatment of cancer |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101257912A Active level portion of polar solvent extract of euphorbiaceae plant latex |
| 09/03/2008 | CN101257909A Core 2 glcnac-t inhibitors |
| 09/03/2008 | CN101257903A Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment |
| 09/03/2008 | CN101255442A LMP-1 recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255441A AFP recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255418A Human heparinase RNA interference target sequence and uses thereof |
| 09/03/2008 | CN101255199A Method for extracting Siberian solomonseal rhizome polysaccharide from siberian solomonseal rhizome |
| 09/03/2008 | CN101255196A Immune globulin single variant antigen bonding land and specificity construction body thereof |
| 09/03/2008 | CN101255190A Use of human midkine protein blocking peptide in preparation of antitumor medicament |
| 09/03/2008 | CN101255186A Tripterygium wilfordii diterpenes diterpenoids lactones derivative and uses thereof |
| 09/03/2008 | CN101255179A Novel amylaceum imine compound as well as preparation method and uses thereof |
| 09/03/2008 | CN101255158A 9-N-substituted berberine derivatives as well as preparation method and use as anti-cancer drugs |
| 09/03/2008 | CN101255154A Substituted 2-indoline ketone derivatives as well as preparation method and uses thereof |